earnings
TS
NASDAQ · TSHA
Taysha Gene Therapies, Inc.
Healthcare · Biotechnology
$6.09
Down-$0.02 (-0.33%)
Updated Aug 22, 2026, 4:32 AM
SID Score
6.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.51B
- P/E ratio
- -20.4
- Dividend yield
- 0.00%
- 52-week range
- $4.03 – $7.30
- Volume
- 2.83M
- Avg. volume
- 6.31M
Price performance
TSHA price history
1M range · 21 trading sessions · Daily adjusted prices
TSHA closed at $6.09 after 21 trading sessions, up 10.33% for the selected period.
- Last close
- $6.09
- Period change
- +10.33%
- Period low
- $5.46
- Period high
- $6.68
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $6.18 | $6.24 | $6.015 | $6.09 | 2.83M |
| Aug 20, 2026 | $6.04 | $6.30 | $5.92 | $6.11 | 3.4M |
| Aug 19, 2026 | $6.40 | $6.52 | $6.29 | $6.43 | 4.28M |
| Aug 18, 2026 | $6.08 | $6.275 | $6.03 | $6.19 | 1.63M |
| Aug 17, 2026 | $5.93 | $6.27 | $5.82 | $6.21 | 3.05M |
| Aug 14, 2026 | $5.90 | $6.0063 | $5.716 | $5.95 | 2.13M |
| Aug 13, 2026 | $6.40 | $6.40 | $5.94 | $5.99 | 2.18M |
| Aug 12, 2026 | $6.13 | $6.449 | $6.01 | $6.405 | 3.91M |
| Aug 11, 2026 | $6.42 | $6.75 | $6.28 | $6.68 | 4.99M |
| Aug 10, 2026 | $6.48 | $6.60 | $6.2175 | $6.37 | 2.24M |
| Aug 7, 2026 | $6.45 | $6.57 | $6.35 | $6.56 | 1.93M |
| Aug 6, 2026 | $6.39 | $6.55 | $6.28 | $6.34 | 2.11M |
| Aug 5, 2026 | $6.29 | $6.47 | $6.195 | $6.46 | 2.18M |
| Aug 4, 2026 | $5.88 | $6.225 | $5.775 | $6.20 | 3.7M |
| Aug 3, 2026 | $5.89 | $5.96 | $5.63 | $5.78 | 1.96M |
| Jul 31, 2026 | $5.88 | $5.92 | $5.725 | $5.86 | 2.29M |
| Jul 30, 2026 | $5.61 | $5.925 | $5.535 | $5.875 | 3.39M |
| Jul 29, 2026 | $5.41 | $5.785 | $5.33 | $5.61 | 2.7M |
| Jul 28, 2026 | $5.51 | $5.68 | $5.2801 | $5.46 | 2.56M |
| Jul 27, 2026 | $5.67 | $5.98 | $5.54 | $5.54 | 2.37M |
| Jul 24, 2026 | $5.89 | $5.95 | $5.46 | $5.52 | 1.81M |
Latest TSHA news
The latest Smart Investors Daily articles mentioning TSHA.
Stock researchResearch & News · SEC Filings
Loading stock research…

